Quality by design engineered, enhanced anticancer activity of temozolomide and resveratrol coloaded NLC and brain targeting via lactoferrin conjugation in treatment of glioblastoma
- 29 August 2023
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 191, 175-188
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporterBiochemical and Biophysical Research Communications, 2015
- Paliperidone-loaded spherical solid lipid nanoparticlesRSC Advances, 2014
- Bovine lactoferrin binds oleic acid to form an anti-tumor complex similar to HAMLETBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
- Optimization of artemether-loaded NLC for intranasal delivery using central composite designDrug Delivery, 2014
- Preparation and evaluation of transnasal microemulsion of carbamazepineAsian Journal of Pharmaceutical Sciences, 2013
- In Vitro and in Vivo Evaluation of Lactoferrin-Conjugated Liposomes as a Novel Carrier to Improve the Brain DeliveryInternational Journal of Molecular Sciences, 2013
- Resveratrol Enhances the Antitumor Effects of Temozolomide in Glioblastoma via ROS‐dependent AMPK‐TSC‐mTOR Signaling PathwayCNS Neuroscience & Therapeutics, 2012
- Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagyFree Radical Biology and Medicine, 2012
- Bioavailability of resveratrolAnnals of the New York Academy of Sciences, 2011
- Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation StudyAAPS PharmSciTech, 2011